First of two interactive presentations features ImClone Systems, a global biopharmaceutical company and innovators of ERBITUX® (cetuximab), novel therapy for advanced head and neck cancer.
Wayne, PA (PRWEB) January 26, 2009 -- MODA Technology Partners will be launching its Paperless QC Micro Webinar Series on February 10, 2009, 11:00-11:45 am (Eastern Standard Time). The live, interactive presentation will focus on Automating Environmental Monitoring, Utility and Product Testing and will feature Robert Lutskus, QCMLS Supervisor at ImClone Systems.
ImClone is global biopharmaceutical company and innovators of ERBITUX® (cetuximab), novel therapy for advanced head and neck cancer. ImClone is a wholly-owned subsidiary of Eli Lilly and Company that utilizes the MODA-EM platform for improved Environmental Monitoring and Utility Testing. The Webinar will be co-sponsored by Applied Biosystems and the Particle Counting Division of Hach Company.
With increased production demands of modern therapies--vaccines, injected drugs, human tissue--more aseptic processing conditions are required so that manufacturing facilities can ensure potential viable and non-viable contamination are under control. The paper-based, labor-intensive environment monitoring programs that are so prevalent in the industry are not capable of delivering the maximum value desired, and have become very costly to sustain. Mobile and wireless technologies now provide opportunities to automate environment monitoring and quality control SOPs and regulatory compliance.
MODA and ImClone will discuss the following:
To learn more about MODA and the February 10 Webinar, visit http://www.modatp.com.
MODA provides a mobile data acquisition platform that enables quality assurance and quality control organizations to automate their regulated manufacturing processes, including pharmaceuticals and consumer products. MODA's flagship software, MODA-EM™, is a paperless solution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality, and reduced costs. For more information, visit http://www.modatp.com.
About Applied Biosystems (Life Technologies)
Life Technologies (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information, visit http://www.lifetechnologies.com.
With nearly half a century of expertise in analytical instrumentation, The Particle Counting division of Hach Company delivers the best solutions in quality monitoring and process analytics worldwide. Our instruments are coupled with global service expertise for the Life Science Applications. Our research programs and innovation ensure that our customers meet regulations and optimize quality throughout their processes. Hach Company is a wholly owned subsidiary of Danaher Corporation, a fortune 500 leader. For more information, visit http://www.hach.com/hua.
Read the full story at http://www.prweb.com/releases/2009/01/prweb1916064.htm.
Copyright©2009 Vocus, Inc.
All rights reserved